Emyria Limited

ASX (AUD): Emyria Limited (EMD)

Last Price

0.031

Today's Change

+0.002 (6.89%)

Day's Change

0.029 - 0.031

Trading Volume

7,752,189

Profile
EMD

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Gregory Hutchinson Gregory Hutchinson

Full Time Employees:  0 0

IPO Date:  2020-02-11 2020-02-11

CIK: 

ISIN:  AU0000073645 AU0000073645

CUSIP:  Q34650103 Q34650103

Beta:  0.58 0.58

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.

Address

D2, 661 Newcastle Street,
Leederville, WA 6007, AU

61 8 6559 2800

http://emyria.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment